In the news release, Natera, Inc. Announces Fourth Quarter and Fiscal 2018 Earnings Conference Call, issued 05-Mar-2019 by Natera, Inc. over PR Newswire, we are advised by the company that the first paragraph, last sentence, as well as the ‘Earnings Conference Call Information" section should read "4:30 p.m. ET (1:30 p.m. PT)" rather than "4 p.m. ET (1 p.m. PT)" as originally issued inadvertently. The complete, corrected release follows:
Natera, Inc. Announces Fourth Quarter and Fiscal 2018 Earnings Conference Call
Natera Also to Present at 39th Annual Cowen Healthcare Conference
SAN CARLOS, Calif., March 5, 2019 /PRNewswire/ — Natera, Inc. (NASDAQ: NTRA), a leader in cell-free DNA, today announced that it will release results for its fourth quarter and year ended December 31, 2018, after the market close on March 12, 2019. Natera will host a conference call and webcast at 4:30 p.m. ET (1:30 p.m. PT) to discuss its financial results, business activities, and financial outlook.
Natera CEO Steve Chapman is also scheduled to present at the 39th Annual Cowen Healthcare Conference in Boston on March 13, 2019, at 11:20 a.m. ET (8:20 a.m. PT).
Earnings Conference Call Information:
Natera’s Fourth Quarter and Year-End 2018 Financial Results
Tuesday, March 12, 2019
4:30 p.m. ET (1:30 p.m. PT)
(877) 823-0171, Domestic
(617) 500-6932, International
A webcast replay will be available at investor.natera.com.
Cowen Healthcare Conference Details:
39th Annual Cowen Healthcare Conference
Wednesday, March 13, 2019
11:20 a.m. ET (8:20 a.m. PT)
Interested parties can access the live webcast with accompanying slides at http://wsw.com/webcast/cowen52/ntra/.
The webcast replay will be available one hour after the conclusion of the live presentation and archived for 90 days.
Natera is a global leader in cell-free DNA testing. The mission of the company is to change the management of disease worldwide. Natera operates an ISO 13485-certified and CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, Calif. It offers a host of proprietary genetic testing services to inform physicians who care for pregnant women, researchers in cancer including bio pharmaceutical companies, and genetic laboratories through its cloud-based software platform. For more information, visit natera.com. Follow Natera on LinkedIn and Twitter.
Investor Relations: Mike Brophy, CFO, Natera, Inc., 650-249-9090
Media: Andrea Sampson, Sullivan & Sampson, 714-374-6174, email@example.com
SOURCE Natera, Inc.